Cabometyx and Staphylococcal infection - a phase IV clinical study of FDA data

Summary:

Staphylococcal infection is reported as a side effect among people who take Cabometyx (cabozantinib s-malate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin D, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Staphylococcal infection when taking Cabometyx. It is created by eHealthMe based on reports of 35,066 people who have side effects when taking Cabometyx from the FDA, and is updated regularly.

What is Cabometyx?

Cabometyx has active ingredients of cabozantinib s-malate. eHealthMe is studying from 35,069 Cabometyx users. Check the latest studies of Cabometyx.

What is Staphylococcal infection?

Staphylococcal infection (an infection with staphylococcus bacteria) is found to be associated with 1,722 drugs and 1,898 conditions by eHealthMe. Check the latest studies of Staphylococcal infection.

On Jul, 18, 2026

35,066 people reported to have side effects when taking Cabometyx.
Among them, 18 people (0.05%) have Staphylococcal infection.

Could Cabometyx cause Staphylococcal infection?

Among these 18 people:

How long have people been on Cabometyx when they have Staphylococcal infection? *

What is the gender of people who have Staphylococcal infection when taking Cabometyx? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Staphylococcal infection when taking Cabometyx? *

What are other drugs people take besides Cabometyx? *

What are other side effects people have besides Staphylococcal infection? *

Fatigue (feeling of tiredness): 5 people, 27.78%
Malignant Neoplasm Progression (cancer tumour came back): 5 people, 27.78%
Weight Decreased: 4 people, 22.22%
Impaired Healing: 4 people, 22.22%
Anaemia (lack of blood): 4 people, 22.22%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 22.22%
Wound Dehiscence (a surgical incision reopens either internally or externally): 3 people, 16.67%
Chronic Kidney Disease: 3 people, 16.67%
Cutaneous Vasculitis (an inflammatory process affecting the vessel wall that leads to its damage): 3 people, 16.67%
Cor Pulmonale Acute (rapid enlargement of the right ventricle of the heart): 3 people, 16.67%

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 13 people, 72.22%
Metastasis (spreadable cancer to other organ from origin): 3 people, 16.67%
Renal Cell Carcinoma Stage Iv (stage iv renal cell cancer have cancer that has spread to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes): 2 people, 11.11%
Metastases To Bone (cancer spreads to bone): 2 people, 11.11%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 5.56%
Renal Neoplasm (kidney tumour): 1 person, 5.56%
Neoplasm Malignant (cancer tumour): 1 person, 5.56%
Muscle Spasms (muscle contraction): 1 person, 5.56%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 5.56%
Metastases To Adrenals (cancer spreads to adrenal gland of kidney): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Cabometyx and have Staphylococcal infection?

- Check whether Staphylococcal infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cabometyx:

Cabometyx (35,069 reports)

Browse all side effects of Cabometyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Staphylococcal infection:

Staphylococcal infection (1,722 drugs)

Browse all the conditions that are associated with Staphylococcal infection:

Staphylococcal infection (1,898 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cabozantinib s-malate (the active ingredients of Cabometyx) and Cabometyx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.